FDA Commissions Study of Premarket Clearance Process for Medical Devices
(FDA: Silver Spring, MD) -- The U.S. Food and Drug Administration announces that it has commissioned the Institute of Medicine (IOM) to study the premarket notification program used to review and clear certain medical devices marketed in the United States.